1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pulmonary Edema Global Clinical Trials Review, H2, 2015

Pulmonary Edema Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Pulmonary Edema Global Clinical Trials Review, H2, 2015" provides an overview of Pulmonary Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Pulmonary Edema Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pulmonary Edema 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Pulmonary Edema to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Pulmonary Edema to Cardiovascular Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Pulmonary Edema 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Pulmonary Edema Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Synvista Therapeutics, Inc. 28
Clinical Trial Overview of Synvista Therapeutics, Inc. 28
GlaxoSmithKline Plc 29
Clinical Trial Overview of GlaxoSmithKline Plc 29
Apex 30
Clinical Trial Overview of Apex 30
Clinical Trial Overview of Top Institutes / Government 31
Mayo Clinic 31
Clinical Trial Overview of Mayo Clinic 31
Tehran University of Medical Sciences 32
Clinical Trial Overview of Tehran University of Medical Sciences 32
Ahvaz Jundishapur University of Medical Sciences 33
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 33
Assistance Publique - Hopitaux de Paris 34
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 34
Centre Hospitalier Universitaire de Clermont-Ferrand 35
Clinical Trial Overview of Centre Hospitalier Universitaire de Clermont-Ferrand 35
Duke University 36
Clinical Trial Overview of Duke University 36
Eunice Kennedy Shriver National Institute of Child Health and Human Development 37
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 37
Helsinki University Central Hospital 38
Clinical Trial Overview of Helsinki University Central Hospital 38
Hyogo College Of Medicine 39
Clinical Trial Overview of Hyogo College Of Medicine 39
Medical University of Vienna 40
Clinical Trial Overview of Medical University of Vienna 40
Five Key Clinical Profiles 41
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 65

List of Tables
Pulmonary Edema Therapeutics, Global, Clinical Trials by Region, 2015* 7
Pulmonary Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pulmonary Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pulmonary Edema Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Pulmonary Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Pulmonary Edema Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Pulmonary Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Pulmonary Edema to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Pulmonary Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Pulmonary Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Pulmonary Edema to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Pulmonary Edema Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Pulmonary Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Pulmonary Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Pulmonary Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Pulmonary Edema Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22
Pulmonary Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Pulmonary Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Pulmonary Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Pulmonary Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Pulmonary Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Synvista Therapeutics, Inc., 2015* 28
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 29
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Apex, 2015* 30
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 31
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 32
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 33
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 34
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Clermont-Ferrand, 2015* 35
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 36
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 37
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2015* 38
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 39
Pulmonary Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 40

List of Figures
Pulmonary Edema Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Pulmonary Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pulmonary Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pulmonary Edema Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Pulmonary Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Pulmonary Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Pulmonary Edema to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Pulmonary Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Pulmonary Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Pulmonary Edema to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Pulmonary Edema Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Pulmonary Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Pulmonary Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Pulmonary Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Pulmonary Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Pulmonary Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Pulmonary Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Pulmonary Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Pulmonary Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 63

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.